David Morin
Internal Medicine · Kingsport, TNNPI 1750533568
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 42 manufacturers reported payments, led by Merck at 44.2% of the total. Reporting peaked in 2021 at $3,252 and has fallen 63.8% since, to $1,178 in 2025. Among internal medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 401 payments — averaging $35.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$6K
- Novo Nordisk AS$2K
- Eli Lilly$2K
- Novo Nordisk$1K
- GSK$342
- AbbVie$336
- plus $3K from 36 others
Across 400 payments — averaging $3539.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.1M
- Novo Nordisk AS$221K
- AstraZeneca$88K
- Applied Therapeutics, Inc.$35K
- Astrazeneca UK Limited$10K
What the payments were for
- Consulting fees$3,18522%
- Travel & lodging$4,84334%
- Food & beverage$6,28444%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$1,561
- GARDASIL 9$900
How this compares
$14,376 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 33 | $36,154 |
| OzempicSemaglutide | 21 | $30,996 |
| EliquisApixaban | 23 | $26,879 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $15,486 |
| FarxigaDapagliflozin Propanediol | 18 | $10,855 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $9,810 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $9,215 |
| Candesartan Cilexetil | 19 | $2,320 |
| Novolin NInsulin Nph Human Isophane | 12 | $1,951 |
| Rosuvastatin Calcium | 94 | $1,525 |
| Atorvastatin Calcium | 76 | $1,484 |
| Metformin Hcl ErMetformin Hcl | 82 | $1,063 |
| Metoprolol Succinate | 39 | $814 |
| Pantoprazole Sodium | 36 | $455 |
| Bisoprolol Fumarate | 13 | $452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $72 | $36,15433 claims |
| Novo NordiskOzempic | $1,126 | $30,99621 claims |
| PfizerEliquis | $272 | $26,87923 claims |
| AstraZenecaFarxiga | $194 | $10,85518 claims |
| GSKTrelegy Ellipta | $342 | $9,81016 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $115 | $9,21511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Kingsport
- Sam SadeghiKingsport$16K
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Devin ShermanFranklin$191K
- Lewis HagoodKnoxville$143K
- Temidayo AbeNashville$113K
- Kenya KozawaSweetwater$86K
- Wayne RileyNashville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.